Dr. Anderson's Financial Disclosure
At this time, there is no standard regarding informing patients
about financial issues related to the practice of medicine. However,
I believe patients and potential patients should be aware of the
financial relationships that can exist between physicians and other
parties, including pharmaceutical companies. Because I believe in
informing patients, I have prepared the following information.
As you know, physicians have to have continuing education. They have
to keep up with the new information. Financing for much of the
education comes from pharmaceutical companies. In some cases, the
pharmaceutical companies provide "unrestricted educational grants"
meaning that they help pay for the education but have NO control
over what is said or discussed. Those are called "continuing medical
education" lectures and the pharmaceutical companies typically are
not allowed to even hear or attend the lecture; these lectures are
reviewed in advance by a committee to make sure that they have no
commercial bias.
I often provide continuing medical education lectures. Although these
lectures usually are funded by pharmaceutical companies, sometimes I don't
even know which company sponsored the lecture. However, the
companies have no
control over the content of the lecture. They are providing a
service to the medical community. Again, these lectures are reviewed
by a medical committee to make sure that they do not have any
commercial bias.
There is another type of lecture. In some cases, the pharmaceutical
companies provide education about disease states for which they make
a particular drug, often with mention of that drug. Those lectures
are called "medical education lectures." Those lectures are reviewed
by the FDA and have to be in compliance with government regulations.
Some newspapers like to report that "Doctors who prescribe a lot of
drug X are rewarded by being paid to speak about drug X." Although
that sounds good in a newspaper, it is not entirely true. If a
physician has a lot of experience with a certain medication, it
makes sense that a pharmaceutical company would ask that physician
to share that expertise with others. A physician who NEVER
prescribed certain drug certainly would NOT be able to discuss it
with others.
I often provide medical education lectures. For those medications
for which I have good expertise, I have been asked to help other
physicians and other practitioners better understand them, their
risks and their appropriate uses. These lectures are monitored by
the FDA and I am subject to federal charges/indictment if I vary
from the FDA rules.
It is worth adding that there is a belief that physicians are paid
to prescribe certain medications. Please be assured that there are
NO payments, NO kickbacks and NO other rebates (or whatever) for
having prescribed any drug. This is an incorrect but popular myth.
All this being said, if any patient would prefer that I do not
prescribe a medication made by a company that has at one time or
another sponsored one of my lectures, I am pleased to find an
alternative. This information is presented on a poster in each of my
examination rooms as well.
Again, honesty is a good policy.
Finally, at this time, I am aware of no significant
investment/stocks in any pharmaceutical, hospital, insurance or
medical device company. I have no financial interest in any
pharmacy, laboratory, surgery center or diagnostic imaging center.
Someday, this type of information will be required by law. Until
then, I will provide it voluntarily here on the web, as I have
always done in my office.
-Dr. Anderson